159 related articles for article (PubMed ID: 29216804)
1. The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Pak VN
Ther Deliv; 2018 Jan; 9(1):37-46. PubMed ID: 29216804
[TBL] [Abstract][Full Text] [Related]
2. α-fetoprotein-binding toxins and teratogens against cancer.
Pak VN
Ther Deliv; 2019 Jan; 10(1):1-3. PubMed ID: 30730821
[No Abstract] [Full Text] [Related]
3. Myeloid-Derived Suppressor Cells.
Gabrilovich DI
Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
[TBL] [Abstract][Full Text] [Related]
4. [Alpha-fetoprotein immunotherapy as a stage of combined treatment of cancer patients].
Chereshnev VA; Rodionov SIu; Vasil'ev NV; Orlov OA; Cherkasov VA
Vopr Onkol; 2005; 51(1):86-92. PubMed ID: 15909814
[TBL] [Abstract][Full Text] [Related]
5. Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors.
Stahl M; Gedrich R; Peck R; LaVallee T; Eder JP
Immunotherapy; 2016 Jun; 8(7):767-74. PubMed ID: 27349976
[TBL] [Abstract][Full Text] [Related]
6. Roles of estrogens on myeloid-derived suppressor cells in cancer and autoimmune diseases.
Ren J; Hou Y; Wang T
Cell Mol Immunol; 2018 Jul; 15(7):724-726. PubMed ID: 29276217
[No Abstract] [Full Text] [Related]
7. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
Ko HJ; Kim YJ
Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells: Multi-talented immune suppressive cells that can be either helpful or harmful.
Cell Immunol; 2021 Jul; 365():104374. PubMed ID: 34038759
[No Abstract] [Full Text] [Related]
9. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
Wilkerson A; Kim J; Huang AY; Zhang M
Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
[TBL] [Abstract][Full Text] [Related]
10. Myeloid derived suppressor cells and autoimmunity.
Boros P; Ochando J; Zeher M
Hum Immunol; 2016 Aug; 77(8):631-636. PubMed ID: 27240453
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.
Tuettenberg A; Steinbrink K; Schuppan D
Nanomedicine (Lond); 2016 Oct; 11(20):2735-2751. PubMed ID: 27658725
[TBL] [Abstract][Full Text] [Related]
12. Myeloid suppressor cells in cancer and autoimmunity.
Sica A; Massarotti M
J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
[TBL] [Abstract][Full Text] [Related]
13. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.
Mizejewski GJ
Expert Rev Anticancer Ther; 2002 Dec; 2(6):709-35. PubMed ID: 12503217
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
Wegner A; Verhagen J; Wraith DC
Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
[TBL] [Abstract][Full Text] [Related]
15. Innate immune cells for immunotherapy of autoimmune and cancer disorders.
Schäfer C; Ascui G; Ribeiro CH; López M; Prados-Rosales R; González PA; Bueno SM; Riedel CA; Baena A; Kalergis AM; Carreño LJ
Int Rev Immunol; 2017 Nov; 36(6):315-337. PubMed ID: 28933579
[TBL] [Abstract][Full Text] [Related]
16. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
17. MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Dudich E
Curr Opin Mol Ther; 2007 Dec; 9(6):603-10. PubMed ID: 18041671
[TBL] [Abstract][Full Text] [Related]
18. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
19. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
20. Expression of checkpoint molecules on myeloid-derived suppressor cells.
Ballbach M; Dannert A; Singh A; Siegmund DM; Handgretinger R; Piali L; Rieber N; Hartl D
Immunol Lett; 2017 Dec; 192():1-6. PubMed ID: 28987474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
